[HTML][HTML] Patient preference for a maintenance inhaler in chronic obstructive pulmonary disease: a comparison of Breezhaler and Respimat
P O'Hagan, J Dederichs, B Viswanad… - Journal of thoracic …, 2018 - ncbi.nlm.nih.gov
Background Good compliance in chronic obstructive pulmonary disease (COPD) is of
'paramount importance'in reducing the occurrence of acute exacerbations, hospitalisation …
'paramount importance'in reducing the occurrence of acute exacerbations, hospitalisation …
[HTML][HTML] Atrial overdrive pacing for sleep apnea: a door now closed?
JS Floras, TD Bradley - American journal of respiratory and critical …, 2005 - atsjournals.org
Asthma remains one of the most common chronic respiratory problems clinicians face. The
AJRCCM is dedicated to bringing its readers not only original research in basic …
AJRCCM is dedicated to bringing its readers not only original research in basic …
Ethnic differences in persistence with COPD medications: a register-based study
Y Hu, L Cantarero-Arévalo, A Frølich… - Journal of racial and …, 2017 - Springer
Abstract Background Long-acting bronchodilators (LABDs) are recommended as a first-line
maintenance therapy in patients with moderate or severe chronic obstructive pulmonary …
maintenance therapy in patients with moderate or severe chronic obstructive pulmonary …
[HTML][HTML] How do patients use their nebuliser in the community?
AC Boyter, R Carter - Respiratory medicine, 2005 - Elsevier
BACKGROUND: Nebulised therapy is commonly used in the management of patients with
asthma and chronic obstructive pulmonary disease (COPD). There are guidelines setting out …
asthma and chronic obstructive pulmonary disease (COPD). There are guidelines setting out …
Can adherence to and persistence with inhaled long-acting bronchodilators improve the quality of life in patients with chronic obstructive pulmonary disease? Results …
G Krack, F Kirsch, L Schwarzkopf, A Schramm… - Clinical Drug …, 2021 - Springer
Abstract Background and Objective Adherence to and persistence with inhaled long-acting
bronchodilators (ILAB), is commonly considered to be a relevant driver of perceived health …
bronchodilators (ILAB), is commonly considered to be a relevant driver of perceived health …
Alcohol consumption, lung function, and quality of life in pneumoconiosis
WK Tang, CM Lum, GS Ungvari… - Alcoholism: Clinical and …, 2005 - Wiley Online Library
Background: To our knowledge, there are no previous data on drinking problems in patients
with pneumoconiosis. The aim of this study was to examine drinking patterns and the impact …
with pneumoconiosis. The aim of this study was to examine drinking patterns and the impact …
Sleep disorders and adherence to inhalation therapy in patients with chronic obstructive pulmonary disease
M Chabowski, J Łuczak, K Dudek… - Advances in Pulmonary …, 2019 - Springer
Sleep disorders are common in patients with chronic obstructive pulmonary disease (COPD)
and are associated with greater disease severity, more frequent exacerbations, greater use …
and are associated with greater disease severity, more frequent exacerbations, greater use …
Consensus Document on Home Nebulization for Maintenance Treatment of Obstructive Airway Diseases: A Joint Initiative by the National Allergy Asthma Bronchitis …
Recent years have seen an increase in the use of nebulizers for delivering maintenance
therapy in obstructive airway diseases (OADs) such as asthma and chronic obstructive …
therapy in obstructive airway diseases (OADs) such as asthma and chronic obstructive …
[HTML][HTML] The lungs need to be deflated: effects of glycopyrronium on lung hyperinflation in COPD patients
CM Sanguinetti - Multidisciplinary Respiratory Medicine, 2014 - Springer
Chronic obstructive pulmonary disease (COPD) is characterized by persistent airflow
limitation caused by bronchial alterations, small airways disease and parenchymal …
limitation caused by bronchial alterations, small airways disease and parenchymal …
Onset of action of formoterol versus salmeterol via dry powder inhalers in moderate chronic obstructive pulmonary disease: a randomized, placebo-controlled, double …
M Cazzola, P Paggiaro, P Palange, L Bjermer… - Clinical drug …, 2012 - Springer
Background: Bronchodilator therapy is central to the symptomatic management of chronic
obstructive pulmonary disease (COPD), and treatment with short-acting bronchodilators is …
obstructive pulmonary disease (COPD), and treatment with short-acting bronchodilators is …